Investing Profile

John McKearn

InvestorVC

Venture Capital / BioPharma R&D

rivervest.com/team-member/joh...United States
Photo of John McKearn, Managing Director at RiverVest
Your Intro Paths to John McKearn

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find John McKearn on

cb
Current Investing Position
RiverVest Managing Director
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
10
Current Fund Size
$184.4M

John McKearn is on these Sector & Stage Rankings

John McKearn's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Wugen
Series BJul 2021$170M
$170M
Co-investors: Bali Muralidhar (Abingworth)
Tioma Therapeutics
Series AAug 2016$86M
$86M
Co-investors: Peter Moldt (Novo Ventures), Jill carroll (SR One), Carole Nuechterlein (Roche Venture Fund)
Allakos
Series ASep 2014$10M
Series AAug 2014$25M
$280M
Co-investors: Paul Walker (New Enterprise Associates (NEA)), Farah Champsi (InterWest)
Otonomy
Series DApr 2014$49M
Series CSep 2013$46M
Series BAug 2010$39M
$140M
Co-investors: Jay Lichter (Avalon Ventures), Peter Bisgaard (Pivotal bioVenture Partners), Brian Dovey (Domain Associates), Bill Harrington (Osage University Partners), Niall O’Donnell (RiverVest), Heather Preston (Pivotal bioVenture Partners)
ZS Pharma
Series DMar 2014$55M
Series COct 2012$46M
$100M
Lumena Pharmaceuticals
Series AMay 2013$23M
$68M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)